GNG4 GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO

Details for Australian Patent Application No. 2002341826 (hide)

Owner DELTAGEN, INC.

Inventors ALLEN, Keith, D.; KIRK, Christopher, J.

Pub. Number AU-A-2002341826

PCT Number PCT/US02/30361

PCT Pub. Number WO2003/026399

Priority 60/324,703 24.09.01 US

Filing date 24 September 2002

Wipo publication date 7 April 2003

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/324,703 24.09.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002341826

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341827-KV1.7 POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO

2002341825-V1A ARGININE VASOPRESSIN RECEPTOR DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO